News

Catheters Market Growth and Trends Analysis

Catheters Market Growth and Trends Analysis

Overview of the Catheters Market

The global catheters market is experiencing substantial growth, with projections indicating it will reach USD 99.30 billion by 2032, up from an estimated USD 53.67 billion in 2023. This impressive growth translates to a compound annual growth rate (CAGR) of 7.2% during the forecast period from 2024 to 2032. The increasing demand for catheters is driven by several factors, including a rise in chronic diseases and a growing preference for minimally invasive surgical procedures.

What Are Catheters?

A catheter is a slender tube-like medical device that plays a vital role in draining urine from the bladder, administering medication or fluids, and assisting in the diagnosis or treatment of heart conditions. During surgical operations involving the bladder, bowel, or urinary tract, catheters are essential for facilitating urine drainage.

These devices are typically made from materials such as rubber, silicone, latex, polyvinyl chloride (PVC), and polyethylene. The main types of catheters include urinary, intravenous, and cardiac catheters, which can be used either temporarily or permanently, depending on the treatment needs.

Key Attributes of the Market

Several important attributes characterize the catheters market:

  • Market value in 2023: USD 53.67 billion
  • Projected market value by 2032: USD 99.30 billion
  • Compound Annual Growth Rate (CAGR): 7.2% from 2024 to 2032
  • Base Year: 2023
  • Historical Data: 2019–2022
  • Forecast Period: 2024–2032

Factors Driving Growth and Trends

Several trends and factors are contributing to the growth of the catheters market:

Increased Demand for Minimally Invasive Surgeries

The growing preference for minimally invasive surgical techniques, especially among patients suffering from Peripheral artery disease (PAD), is driving the demand for catheterization methods. Angioplasty procedures are becoming more common than traditional surgeries due to their effectiveness, which in turn supports market growth.

Rising Incidence of Chronic Diseases

As chronic diseases such as diabetes, renal issues, and cardiovascular conditions continue to rise, the need for diagnostic procedures is also increasing, leading to a higher demand for catheters. Global health statistics show that noncommunicable diseases account for a significant portion of deaths worldwide.

Technological Innovations

Recent advancements, including the creation of smaller catheters and the use of antimicrobial coatings, are improving patient outcomes and safety, further propelling market growth. Companies in the market are increasingly focusing on these innovations to meet the demand for enhanced surgical capabilities.

Increasing Cardiovascular Disease Rates

Due to lifestyle changes and unhealthy habits, there has been a marked rise in cardiovascular diseases, which is driving the need for various catheter-related medical procedures and contributing to overall market growth.

Regional Insights

North America currently leads the global catheters market, primarily due to an aging population and a high prevalence of chronic diseases. The region benefits from the presence of major manufacturers and an increasing awareness of the importance of early diagnosis and treatment, which enhances market dynamics.

Leading Companies in the Catheters Market

Prominent players in the catheters market include:

  • Abbott Laboratories
  • Braun Melsungen AG
  • Becton Dickson and Company
  • Boston Scientific Corporation
  • ConvaTec Group Plc
  • Cure Medical LLC
  • Edward Lifesciences
  • Hollister Incorporated
  • Johnson & Johnson Inc.
  • Medtronic
  • Smith Medical Inc.
  • Teleflex Incorporated
  • Manfred Sauer
  • Stryker Corporation
  • Dentsply Sirona Inc.

Frequently Asked Questions

What is the projected value of the catheters market by 2032?

The catheters market is projected to reach USD 99.30 billion by 2032.

What is a catheter used for?

A catheter is utilized for draining urine, delivering medication or fluids, and assisting in the diagnosis or treatment of heart conditions.

Which regions contribute significantly to the catheters market?

North America plays a significant role, with substantial market shares owing to an aging population and the increasing prevalence of chronic diseases.

What technological advancements are impacting the catheters market?

Technological advancements include the development of smaller, safer catheters and the integration of antimicrobial coatings to minimize complications.

Who are the key players in the global catheters market?

Key players in the market include companies such as Abbott Laboratories, Boston Scientific Corporation, Medtronic, and Johnson & Johnson Inc.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 15

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 6

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 6

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 7

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 7

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 6

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 3

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 6

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading

Top 5 Most Recently Viewed Articles

Rocky Shore Gold Completes Initial Private Placement Tranche

Updated Category News Views 118

Rocky Shore Gold Completes Initial Private Placement Tranche Rocky Shore Gold Ltd. (CSE: RSG) has successfully announced the completion of the first tranche of its non-brokered private placement, raising significant funds to support its ongoing projects. The financing initiative, which was previously publicized, demonstrates the company's commitment to advancing its...

Continue Reading
Monthly Dividend Announcement from Ellington Credit Company

Updated Category News Views 185

Ellington Credit Company Declares Monthly Dividend Ellington Credit Company (NYSE: EARN) has made an exciting announcement regarding its financial commitment to its shareholders. The company's Board of Trustees has declared a monthly common dividend, establishing an amount of $0.08 per share. This dividend will be payable shortly, offering a tangible return to those...

Continue Reading
Halide Alagoz Sells Over $1.5 Million in Ralph Lauren Shares

Updated Category News Views 128

Halide Alagoz Completes Significant Stock Sale Recent reports indicate that Halide Alagoz, the Chief Product Officer at Ralph Lauren, executed a substantial insider sale according to official filings. Details of the Insider Transaction According to regulatory disclosures, Alagoz sold 5,282 shares of Ralph Lauren, resulting in a total transaction value of approximately...

Continue Reading
Midland States Bancorp, Inc. Declares Quarterly Dividends

Updated Category News Views 86

Midland States Bancorp, Inc. Declares Quarterly Cash Dividend Midland States Bancorp, Inc. (NASDAQ: MSBI) recently announced a quarterly cash dividend of $0.31 per share for its common stock. This dividend is significant as it highlights the company’s commitment to delivering value to its shareholders. The payment will be available to shareholders of record on a...

Continue Reading
Standex International Sees Price Target Increase Amid Growth

Updated Category News Views 55

Standex International's Price Target Raised by DA Davidson Recently, Standex International (NYSE: SXI) experienced a notable increase in its price target, now set at $222.00, from analysts at DA Davidson. This update follows the company's fiscal year 2025 earnings report, coinciding with their performance in the third quarter of the calendar year. The previous price...

Continue Reading